ConductScience.org, home

Paper16701232

Genetic details, optimization and phage life histories.

Bull JJ and 2 others. Trends Ecol Evol, 2004. Cited by 53 papers, by iCite.

Cite this record

ConductScience Library. Genetic details, optimization and phage life histories. Papers, record 16701232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16701232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Genetic details, optimization and phage life histories.
PubMed
Journal
Trends Ecol Evol
PubMed
Year
2004
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
53
iCite
Relative citation ratio, by iCite
1.17
iCite
Revised in PubMed
2006-05-16
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bull JJJ J
2Pfennig DWDavid W
3Wang INIng-Nang

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Cited by33

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 53 citations.

PMIDTitleJournalYearIn PapersSource
42455954Inferring single-cell heterogeneity of bacteriophage lysis-associated life-history traits from population-scale dynamics.Sci Adv2026https://conductscience.org/library/papers/42455954PubMed
40143293Infection and Genomic Properties of Single- and Double-Stranded DNA Cellulophaga Phages.Viruses2025https://conductscience.org/library/papers/40143293PubMed
37298457Isolation, Characterization, and Comparative Genomic Analysis of Bacteriophage Ec_MI-02 from Pigeon Feces Infecting Escherichia coli O157:H7.Int J Mol Sci2023https://conductscience.org/library/papers/37298457PubMed
35620963Biological foundations of successful bacteriophage therapy.EMBO Mol Med2022https://conductscience.org/library/papers/35620963PubMed
35467417An Optimal Lysis Time Maximizes Bacteriophage Fitness in Quasi-Continuous Culture.mBio2022https://conductscience.org/library/papers/35467417PubMed
34339297Phage-encoded cationic antimicrobial peptide required for lysis.J Bacteriol2021https://conductscience.org/library/papers/34339297PubMed
31623057Look Who's Talking: T-Even Phage Lysis Inhibition, the Granddaddy of Virus-Virus Intercellular Communication Research.Viruses2019https://conductscience.org/library/papers/31623057PubMed
27497318Evolved Populations of Shigella flexneri Phage Sf6 Acquire Large Deletions, Altered Genomic Architecture, and Faster Life Cycles.Genome Biol Evol2016https://conductscience.org/library/papers/27497318PubMed
27392606Mechanisms of viral mutation.Cell Mol Life Sci2016https://conductscience.org/library/papers/27392606PubMed
26921293Genetically Determined Variation in Lysis Time Variance in the Bacteriophage φX174.G3 (Bethesda)2016https://conductscience.org/library/papers/26921293PubMed
24585055Phage lysis: three steps, three choices, one outcome.J Microbiol2014https://conductscience.org/library/papers/24585055PubMed
24554658Delayed lysis confers resistance to the nucleoside analogue 5-fluorouracil and alleviates mutation accumulation in the single-stranded DNA bacteriophage ϕX174.J Virol2014https://conductscience.org/library/papers/24554658PubMed
24225463Fitness benefits of low infectivity in a spatially structured population of bacteriophages.Proc Biol Sci2014https://conductscience.org/library/papers/24225463PubMed
24158484How optimal foragers should respond to habitat changes: a reanalysis of the Marginal Value Theorem.J Math Biol2014https://conductscience.org/library/papers/24158484PubMed
23516359Evolution of virulence in emerging epidemics.PLoS Pathog2013https://conductscience.org/library/papers/23516359PubMed
23275871Thinking about microcolonies as phage targets.Bacteriophage2012https://conductscience.org/library/papers/23275871PubMed
22904283The spanin complex is essential for lambda lysis.J Bacteriol2012https://conductscience.org/library/papers/22904283PubMed
21187415Holin triggering in real time.Proc Natl Acad Sci U S A2011https://conductscience.org/library/papers/21187415PubMed
20646132Optimality models in the age of experimental evolution and genomics.J Evol Biol2010https://conductscience.org/library/papers/20646132PubMed
20643740Unrestricted migration favours virulent pathogens in experimental metapopulations: evolutionary genetics of a rapacious life history.Philos Trans R Soc Lond B Biol Sci2010https://conductscience.org/library/papers/20643740PubMed

See all 33 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16701232

GET https://conductscience.org/api/papers/v1/16701232/cited_by?page=2